Jeffrey Calabrese - 01 Jul 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC

Role: Vice President of Finance
Signature: /s/ John W. LaRocca, Attorney-in-Fact for Jeffrey Calabrese
Issuer symbol: N/A
Transactions as of: 01 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 06 Jul 2022, 16:44:13 UTC
Previous filing: 08 Nov 2021
Next filing: 16 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AERI	Common Stock	Award	$0	+11,276	+141%	$0.000000	19,295	01 Jul 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AERI	Stock Option (right to buy)	Award	$0	+20,774		$0.000000	20,774	01 Jul 2022	Common Stock	20,774	$8.36	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of July 1, 2022.
F2	This Option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of July 1, 2022.